Literature DB >> 12195840

Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease.

G Pitsiou1, G Kyriazis, O Hatzizisi, P Argyropoulou, E Mavrofridis, D Patakas.   

Abstract

Weight loss has been recognized as a feature of advanced emphysema and a factor of poor prognosis, but its mechanisms remain obscure. Studies have demonstrated high serum concentrations of TNF-a (cachexin) in chronic obstructive pulmonary disease (COPD) patients with emphysema. Pink puffers (PP) COPD patients have worse tissue oxygenation when compared with blue bloaters (BB) COPD patients. Consequently, PP patients would become cachectic, whereas BB patients with better tissue oxygenation would not. The aim of this study is to test the hypothesis that malnutrition in emphysema is a cytokine-mediated marker of chronic progressive tissue hypoxia. Thirty male COPD patients, without clinical or laboratory evidence of infection and severe air way obstruction (FEV1 < 1.5 l) were allocated: 16 as pink puffers (PP) and 14 as blue bloaters (BB). Lung function measurements included FEV1, FVC, RV, TLC, DLCO and arterial blood gases on room air. TNF-a serum levels were measured by immunoenzymic method (ELISA). Tissue oxygenation was assessed from oxygen delivery (DO2), PvO2 and oxygen extraction ratio (O2ER) obtained after right heart catheterization with Swan Ganz catheter. PP patients demonstrated lower DLCO and higher TLC, FRC and PaO2 from BB. We found that oxygen delivery was better in our BB than in PP patients (CI 2.9 +/- 0.2 vs 2.5 +/- 0.4 l/min/m2--P < 0.01, DO2 16.1 +/- 2.1 vs 13.1 +/- 0.2 ml/min/kg--P < 0.001) and the same was found for tissue oxygenation (PvO2 34.6 +/- 2.9 vs 31.2 +/- 3.8 mmHg--P < 0.01, O2ER 0.27 +/- 0.02 vs 0.34 +/- 0.06%--P < 0.001). The TNF-a values were higher in PP (31.3 +/- 26 pg/ml vs 15.2 +/- 9.9 pg/ml--P < 0.05) and their percent fat-free mass (%FFM) was 49.6 +/- 11.5 vs 42 +/- 8%--P < 0.001. We found that COPD patients with lower DO2 had increased TNF-a levels; but the correlations between TNF-a serum levels and PvO2 or O2ER were not statistically significant. TNF-a levels were elevated in PP patients with tissue hypoxia and may be a factor contributing to the weight loss of these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195840     DOI: 10.1053/rmed.2002.1322

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  17 in total

1.  High levels of soluble tumor necrosis factor receptors 1 and 2 and their association with mortality in patients undergoing hemodialysis.

Authors:  Axel C Carlsson; Juan-Jesús Carrero; Peter Stenvinkel; Matteo Bottai; Peter Barany; Anders Larsson; Johan Ärnlöv
Journal:  Cardiorenal Med       Date:  2015-01-30       Impact factor: 2.041

2.  Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammation.

Authors:  Narsa M Reddy; Suryanaraya Vegiraju; Ashley Irving; Bogdan C Paun; Irina G Luzina; Sergei P Atamas; Shyam Biswal; Navas-Acien Ana; Wayne Mitzner; Sekhar P Reddy
Journal:  Am J Pathol       Date:  2012-02       Impact factor: 4.307

Review 3.  Cell death, remodeling, and repair in chronic obstructive pulmonary disease?

Authors:  Peter M Henson; R William Vandivier; Ivor S Douglas
Journal:  Proc Am Thorac Soc       Date:  2006-11

Review 4.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

5.  Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

Authors:  Elizabeth Sapey; Ali Ahmad; Darren Bayley; Paul Newbold; Noel Snell; Paul Rugman; Robert A Stockley
Journal:  J Clin Immunol       Date:  2009-03-17       Impact factor: 8.317

Review 6.  Reversal of chronic obstructive pulmonary disease-associated weight loss : are there pharmacological treatment options?

Authors:  Jean K Berry; Charles Baum
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Soluble TNF receptors and kidney dysfunction in the elderly.

Authors:  Axel C Carlsson; Tobias E Larsson; Johanna Helmersson-Karlqvist; Anders Larsson; Lars Lind; Johan Ärnlöv
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

8.  Soluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.

Authors:  Axel C Carlsson; Lina Nordquist; Tobias E Larsson; Juan-Jesús Carrero; Anders Larsson; Lars Lind; Johan Ärnlöv
Journal:  Cardiorenal Med       Date:  2015-07-31       Impact factor: 2.041

Review 9.  Targeted treatment in COPD: a multi-system approach for a multi-system disease.

Authors:  David Anderson; William Macnee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-01

10.  The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease.

Authors:  Sheryl F Vondracek; Norbert F Voelkel; Michael T McDermott; Connie Valdez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.